Production (Stage)
Molecular Partners AG
MOLN
$3.87
-$0.1314-3.29%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -100.00% | |||
| Cost of Revenue | 23.24% | -14.34% | |||
| Gross Profit | -23.24% | 8.61% | |||
| SG&A Expenses | -22.86% | 19.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.59% | -4.58% | |||
| Operating Income | -6.59% | 0.12% | |||
| Income Before Tax | -45.90% | 32.57% | |||
| Income Tax Expenses | -195.65% | -- | |||
| Earnings from Continuing Operations | -45.86% | 32.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -45.86% | 32.56% | |||
| EBIT | -6.59% | 0.12% | |||
| EBITDA | -4.69% | -2.36% | |||
| EPS Basic | -45.88% | 39.31% | |||
| Normalized Basic EPS | -45.92% | 39.32% | |||
| EPS Diluted | -45.00% | 38.94% | |||
| Normalized Diluted EPS | -45.92% | 39.32% | |||
| Average Basic Shares Outstanding | -0.02% | 11.12% | |||
| Average Diluted Shares Outstanding | -0.02% | 11.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||